Neuropathix, Inc. Stock
Equities
NPTX
US64132Q1094
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 18-07-24 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Timothy Scott
BRD | Director/Board Member | 71 | 18-07-24 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.30% | 21.66B | |
-18.35% | 20.77B | |
-8.49% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |